Who Paid My Doc
Jeffrey Bornstein
Pediatric Gastroenterology Orlando, FL Medical Doctor
NPI 1649389404 CMS profile 165330
60 W Gore St, Orlando, FL 32806
General payments
$34,787
Research payments
$966
Ownership & investment interest
$0
Research they led as principal investigator
$134,808
Through program year 2025, Jeffrey Bornstein of Orlando, FL is reported in the CMS Open Payments database as having received $34,787 across 135 general payments and $966 in research payments paid to them. Separately, studies naming them as principal investigator received $134,808 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,218 | 29 | |
| 2024 | General | $756 | 24 | |
| 2023 | General | $6,747 | 32 | |
| 2023 | Research | $966 | 1 | |
| 2022 | General | $4,205 | 13 | |
| 2021 | General | $4,431 | 11 | |
| 2020 | General | $5,325 | 11 | |
| 2019 | General | $12,104 | 15 |
Beside peers
- Jeffrey Bornstein
- Pediatric Gastroenterology median
- Middle half of Pediatric Gastroenterology
- National median
In program year 2025, general payments to Jeffrey Bornstein were reported at $1,218. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.
Show as a table
| Year | Jeffrey Bornstein | Pediatric Gastroenterology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $12,104 | $131 | $41–$311 | $163 |
| 2020 | $5,325 | $79 | $23–$223 | $114 |
| 2021 | $4,431 | $104 | $32–$321 | $132 |
| 2022 | $4,205 | $125 | $37–$331 | $149 |
| 2023 | $6,747 | $169 | $55–$440 | $160 |
| 2024 | $756 | $196 | $73–$563 | $164 |
| 2025 | $1,218 | $194 | $81–$540 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
136 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Gastroenterology in Florida
Yamen Smadi
Pediatric Gastroenterology · Orlando, FL
Regino Gonzalez-Peralta
Pediatric Gastroenterology · Orlando, FL
Akash Pandey
Pediatric Gastroenterology · Orlando, FL
Shaista Safder
Pediatric Gastroenterology · Orlando, FL
Alisa Muniz Crim
Pediatric Gastroenterology · Miami, FL
Aymin Delgado
Pediatric Gastroenterology · Naples, FL
Related records
Pediatric Gastroenterology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Gastroenterology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.